|
Volumn 7, Issue 8, 2015, Pages 1229-1232
|
Copper(i) targeting in the Alzheimer's disease context: A first example using the biocompatible PTA ligand
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BIOCOMPATIBILITY;
LIGANDS;
METAL IONS;
NEURODEGENERATIVE DISEASES;
ALZHEIMER'S DISEASE;
COORDINATING LIGANDS;
COPPER IONS;
OLIGOMER FORMATIONS;
REDOX STATE;
COPPER COMPOUNDS;
1,3,5 TRIAZA 7 PHOSPHAADAMANTANE;
ADAMANTANE DERIVATIVE;
AMYLOID BETA PROTEIN;
BIOMATERIAL;
CHELATING AGENT;
COPPER;
COPPER ION;
LIGAND;
MEMANTINE;
OLIGOMER;
REACTIVE OXYGEN METABOLITE;
UNCLASSIFIED DRUG;
1,3,5-TRIAZA-7-PHOSPHAADAMANTANE;
ADAMANTANE;
ORGANOPHOSPHORUS COMPOUND;
ABSORPTION;
ALKYLATION;
ALZHEIMER DISEASE;
ARTICLE;
ARYLATION;
BIOCOMPATIBILITY;
FIBER;
FLUORESCENCE;
LAG TIME;
NUCLEAR MAGNETIC RESONANCE;
OXIDATION;
OXIDATION REDUCTION STATE;
PRIORITY JOURNAL;
ANALOGS AND DERIVATIVES;
CHEMISTRY;
HUMAN;
ISOLATION AND PURIFICATION;
METABOLISM;
OXIDATION REDUCTION REACTION;
ADAMANTANE;
ALZHEIMER DISEASE;
AMYLOID BETA-PEPTIDES;
COPPER;
HUMANS;
ORGANOPHOSPHORUS COMPOUNDS;
OXIDATION-REDUCTION;
REACTIVE OXYGEN SPECIES;
|
EID: 84938769682
PISSN: 17565901
EISSN: 1756591X
Source Type: Journal
DOI: 10.1039/c5mt00077g Document Type: Article |
Times cited : (34)
|
References (25)
|